Metabolic syndrome-associated risk factors and hs-CRP independently predicted arterial stiffness, with baPWV increasing progressively with the number of risk factors (P for trend <0.001).
Cross-Sectional (n=9,903)
Do metabolic syndrome-associated risk factors and hs-CRP predict arterial stiffness in subjects with and without chronic kidney disease?
Metabolic syndrome-associated risk factors and hs-CRP are independent determinants of arterial stiffness in both CKD and non-CKD subjects, while renal function decline contributes to arterial stiffness specifically in CKD.
p-value: p=<0.001
Metabolic syndrome (MS), high-sensitivity C-reactive protein (hs-CRP), and chronic kidney disease (CKD) are related to cardiovascular diseases. Although MS is common in CKD subjects, the contribution of MS-associated risk factors and hs-CRP to arterial stiffness in CKD has not been well studied.In this cross-sectional cohort study, we enrolled 9903 subjects who underwent brachial-ankle pulse wave velocity (baPWV) measurements from our database of Health Care Center. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m. Comparing those grouped with and without CKD, multivariate linear regression analyses were used.Overall, baPWV was found to have an inverse relationship with eGFR (P for trend <0.001), which increased progressively with the presence of CKD, increasing number of MS-associated risk factors and hs-CRP (P for trend <0.001). In the non-CKD group, age, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting glucose, triglyceride, high-density lipoprotein cholesterol, and hs-CRP independently predicted baPWV, whereas in CKD, eGFR, age, gender, body mass index, SBP, DBP, and fasting glucose remained predictors.The number of MS-associated risk factors and hs-CRP remains a determinant of arterial stiffness in both CKD and non-CKD groups. The decline of renal function contributes to arterial stiffness only in CKD but not in non-CKD. Our findings suggest that for CKD subjects, renal function, BP, and glycemic control are potential targets for further interventional studies of arterial stiffness.
Tsai et al. (Tue,) conducted a cross-sectional in Chronic Kidney Disease and Metabolic Syndrome (n=9,903). Metabolic syndrome-associated risk factors and hs-CRP vs. Absence or lower levels of risk factors was evaluated on brachial-ankle pulse wave velocity (baPWV) (p=<0.001). Metabolic syndrome-associated risk factors and hs-CRP independently predicted arterial stiffness, with baPWV increasing progressively with the number of risk factors (P for trend <0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: